Vertex Pharmaceuticals Inc (VRTX) stock news · P/E 31, rev $12.00B
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US. It is led by Reshma Kewalramani FASN, M.D..
This VRTX news page leads with what Vertex Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for VRTX yet. We will not pad this page with generic market recap.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 30.5.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the VRTX stock page; for the tape open the quote page.
VRTX cached headlines
Newest cached · 2026-09-02T23:05:00.000Z
- 2 Reasons CRISPR Therapeutics Stock Could Soar in the Final 4 Months of 2026 — Yahoo Finance
- How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks? — Yahoo Finance
- Vertex (VRTX) Stock Trades At A Premium On Earnings Yet Looks Fair On Broader Checks — Yahoo Finance
- Goldman Sachs refreshes conviction lists on both sides of the Atlantic — Yahoo Finance
- Vertex Pharmaceuticals (VRTX) Could Be 3% Undervalued If Its Pipeline Growth Holds — Yahoo Finance
- Vertex Completes $10 Billion Crinetics Acquisition, Adding Rare Endocrine Growth Platform — Yahoo Finance
+8 older cached headlines in the full archive.
These headlines as JSON? API free 100/dayVRTX stock news FAQ
What is VRTX's latest news headline?
The latest cached Vertex Pharmaceuticals Inc (VRTX) headline on this page is "2 Reasons CRISPR Therapeutics Stock Could Soar in the Final 4 Months of 2026" from Yahoo Finance on Sep 2, 2026. Story: https://lician.com/news/vrtx/84. News: https://lician.com/news/vrtx
When was the latest cached VRTX headline published?
The latest cached Vertex Pharmaceuticals Inc (VRTX) headline on this page was published Sep 2, 2026. The earliest headline date on this page is Aug 19, 2026.
How many VRTX headlines are listed on this page?
This page lists 14 cached Vertex Pharmaceuticals Inc (VRTX) headlines. News: https://lician.com/news/vrtx
What other VRTX headlines are listed on this page?
Other cached headlines on this Vertex Pharmaceuticals Inc (VRTX) news page: "How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks?"; "Vertex (VRTX) Stock Trades At A Premium On Earnings Yet Looks Fair On Broader Checks"; "Goldman Sachs refreshes conviction lists on both sides of the Atlantic". News: https://lician.com/news/vrtx
What source is listed on the VRTX news page?
The cached source on this Vertex Pharmaceuticals Inc (VRTX) news page is Yahoo Finance. News: https://lician.com/news/vrtx
What does the latest VRTX headline say?
The latest cached Vertex Pharmaceuticals Inc (VRTX) headline is "2 Reasons CRISPR Therapeutics Stock Could Soar in the Final 4 Months of 2026". We'll know a little more about the company's prospects by the end of the year.
What are VRTX's latest revenue and net income?
Latest cached Vertex Pharmaceuticals Inc (VRTX) revenue for Dec 31, 2025 was $12.00B. Net income was $3.95B. Statements: https://lician.com/financials/vrtx
Where is VRTX stock news listed?
Cached stock news for Vertex Pharmaceuticals Inc (VRTX) is listed at https://lician.com/news/vrtx. Filings: https://lician.com/sec/vrtx
Not investment advice.